Skip to content
healthcare.dev

Afinitor Disperz

NDC 0078-0626, everolimus, tablet, for suspension, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0626
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203985
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0626 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS2 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
0078-0626-510007806265128 BLISTER PACK in 1 CARTON (0078-0626-51) / 1 TABLET, FOR SUSPENSION in 1 BLISTER PACK (0078-0626-61)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2150f73a-179b-4afc-b8ce-67c85cc72f04

Use it

Look up 0078-0626 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0626 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.